Pembrolizumab-induced encephalitis in a patient with renal cell carcinoma post nephrectomy: A case report

A new category of immune-related adverse effects has been identified due to increasing use of immune checkpoint inhibitor therapy to treat solid organ cancers. Pembrolizumab approved for renal cell carcinoma also has neurological immune-related adverse effects causing long-term morbidity. We here pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Sharma, Amit, Chapagain, Akhil, Kharel, Sanjeev, Giri, Subarna, Regmi, Arju, Yadav, Rupesh Kumar, Thapaliya, Sahil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850121/
https://www.ncbi.nlm.nih.gov/pubmed/36686204
http://dx.doi.org/10.1177/2050313X221149827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9850121/
https://www.ncbi.nlm.nih.gov/pubmed/36686204
http://dx.doi.org/10.1177/2050313X221149827

Ejemplares similares